Literature DB >> 14759531

(+/-)-Schefflone: a trimeric monoterpenoid from the root bark of Uvaria scheffleri.

Mayunga H H Nkunya1, Stephan A Jonker, René de Gelder, Sabina W Wachira, Charles Kihampa.   

Abstract

The trimeric monoterpene and mildly mosquito larvicidal agent, (+/-)-schefflone, that is an apparent derivative of the antiparasitic aromatic monoterpene espintanol, was isolated from the antimalarial extracts of the root bark of Uvaria scheffleri, together with espintanol. Structural determination of (+/-)-schefflone was achieved from spectroscopic data and confirmed by single-crystal X-ray diffraction analysis. (+/-)-Schefflone can be considered a product of a non-enzymatic Diels-Alder-type cycloaddition reaction of the quinonemethide derivative of espintanol as the diene and dienophile.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14759531     DOI: 10.1016/j.phytochem.2003.10.011

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  4 in total

1.  Hydroxyespintanol and schefflerichalcone: two new compounds from Uvaria scheffleri.

Authors:  Momoyo Ichimaru; Noriyoshi Nakatani; Masataka Moriyasu; Yumi Nishiyama; Atsushi Kato; Simon G Mathenge; Francis D Juma; Patrick B ChaloMutiso
Journal:  J Nat Med       Date:  2009-09-16       Impact factor: 2.343

2.  Insecticidal activity of the essential oil from fruits and seeds of Schinus terebinthifolia Raddi against African malaria vectors.

Authors:  Eliningaya J Kweka; Mramba Nyindo; Franklin Mosha; Ary G Silva
Journal:  Parasit Vectors       Date:  2011-07-05       Impact factor: 3.876

3.  Ethnodiagnostic skills of the digo community for malaria: a lead to traditional bioprospecting.

Authors:  Joseph Mwanzia Nguta; James M Mbaria; Peter K Gathumbi; Daniel Gakuya; John David Kabasa; Stephen Gitahi Kiama
Journal:  Front Pharmacol       Date:  2011-06-24       Impact factor: 5.810

Review 4.  Antimalarial Plants Used across Kenyan Communities.

Authors:  Timothy Omara
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-12       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.